IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 53 filers reported holding IVERIC BIO INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $184,028,311 | +34.5% | 4,677,893 | -16.8% | 0.01% | +25.0% |
Q1 2023 | $136,836,251 | -49.6% | 5,624,178 | -55.6% | 0.01% | 0.0% |
Q4 2022 | $271,343,318 | +142.2% | 12,673,672 | +103.0% | 0.01% | +14.3% |
Q3 2022 | $112,024,000 | +33.3% | 6,244,356 | -28.5% | 0.01% | +40.0% |
Q2 2022 | $84,017,000 | -15.2% | 8,733,590 | +48.3% | 0.01% | 0.0% |
Q1 2022 | $99,126,000 | +2.5% | 5,889,843 | +1.8% | 0.01% | 0.0% |
Q4 2021 | $96,728,000 | +25.7% | 5,785,151 | +22.1% | 0.01% | +25.0% |
Q3 2021 | $76,969,000 | +280.5% | 4,739,458 | +47.8% | 0.00% | +300.0% |
Q2 2021 | $20,228,000 | -11.4% | 3,205,626 | -13.2% | 0.00% | 0.0% |
Q1 2021 | $22,835,000 | -3.2% | 3,694,983 | +8.2% | 0.00% | 0.0% |
Q4 2020 | $23,600,000 | +259.0% | 3,415,272 | +193.1% | 0.00% | – |
Q3 2020 | $6,573,000 | +73.9% | 1,165,414 | +57.3% | 0.00% | – |
Q2 2020 | $3,779,000 | +7940.4% | 741,035 | +1679.1% | 0.00% | – |
Q3 2019 | $47,000 | -13.0% | 41,652 | 0.0% | 0.00% | – |
Q2 2019 | $54,000 | – | 41,652 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 2,914,250 | $28,035,000 | 11.91% |
Ally Bridge Group (NY) LLC | 650,000 | $6,253,000 | 5.70% |
Vivo Capital, LLC | 5,238,634 | $50,396,000 | 5.06% |
COMMODORE CAPITAL LP | 2,409,961 | $23,184,000 | 4.90% |
Finepoint Capital LP | 987,600 | $9,501,000 | 3.28% |
ACUTA CAPITAL PARTNERS, LLC | 563,607 | $5,422,000 | 3.02% |
Deep Track Capital, LP | 4,500,000 | $43,290,000 | 2.85% |
Yiheng Capital Management, L.P. | 5,058,585 | $48,664,000 | 2.78% |
Samsara BioCapital, LLC | 1,010,051 | $9,717,000 | 2.59% |
Ghost Tree Capital, LLC | 500,000 | $4,810,000 | 2.50% |